Physician
Chaparral Medical Group, INC.
Chaparral Medical Group, INC. was paid $11.69M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 23% of everything it billed.
33Billing provider infoCHAPARRAL MEDICAL GROUP, INC.
POMONA, CA 91767
POMONA, CA 91767
33aNPI1437111028assigned 04/06/2006
33bProvider typeHospice and Palliative Medicine (Emergency Medicine) Physician
28Total paid$11.69M
24GClaims573,884
24DCodes billed167
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hospice and Palliative Medicine (Emergency Medicine) Physician providers in California
Rank by total paid#1 of 6
Median peer was paid$9K
This provider vs. median1,323×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 75,109 | $1.29M | |
| 2019 | 106,532 | $1.86M | |
| 2020 | 78,989 | $1.73M | |
| 2021 | 57,248 | $1.39M | |
| 2022 | 76,874 | $1.67M | |
| 2023 | 98,582 | $2.15M | |
| 2024incomplete | 80,550 | $1.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 54,648 | 52,185 | $2.68M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 20% | 25,642 | 10,532 | $2.36M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 14% | 17,175 | 16,533 | $1.62M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 7.6% | 12,769 | 12,393 | $885K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 6.6% | 24,865 | 8,326 | $775K |
| 36478 | 5.8% | 454 | 284 | $682K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.1% | 9,324 | 9,251 | $473K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 2.2% | 1,886 | 1,882 | $256K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.1% | 25,781 | 23,120 | $247K |
| 36475 | 1.6% | 125 | 102 | $186K | |
| 99223 | Prolong inpt eval add15 m | 1.6% | 3,146 | 2,936 | $186K |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1.0% | 3,349 | 3,227 | $117K |
155 more codes
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 15,589 | $102K |
| 93000 | <1% | 4,787 | $101K | |
| 76536 | <1% | 1,276 | $92K | |
| 99205 | Prolong outpt/office vis | <1% | 893 | $90K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 4,178 | $89K |
| 17110 | <1% | 994 | $66K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,902 | $46K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,441 | $40K |
| 93297 | <1% | 2,617 | $40K | |
| 93970 | <1% | 256 | $37K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 251 | $35K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 379 | $34K |
| 93296 | <1% | 1,722 | $34K | |
| 93295 | <1% | 723 | $25K | |
| G9012 | Other specified case management service not elsewhere classified | <1% | 1,578 | $25K |
| 36471 | <1% | 316 | $24K | |
| 77003 | <1% | 1,148 | $21K | |
| 20610 | <1% | 337 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,527 | $20K |
| J3490 | Unclassified drugs | <1% | 481 | $16K |
| 11102 | <1% | 510 | $16K | |
| 93015 | <1% | 220 | $16K | |
| 95811 | <1% | 91 | $14K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,517 | $13K |
| 11901 | <1% | 905 | $13K | |
| 92551 | <1% | 2,019 | $12K | |
| 93294 | <1% | 540 | $9K | |
| 95250 | <1% | 91 | $9K | |
| 64493 | <1% | 217 | $8K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,114 | $8K |
| 99443 | <1% | 325 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 2,430 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 68 | $6K |
| 99152 | <1% | 523 | $6K | |
| 92557 | <1% | 147 | $6K | |
| A4550 | Surgical trays | <1% | 1,560 | $5K |
| 11100 | <1% | 318 | $5K | |
| 2010F | <1% | 26,200 | $5K | |
| 64495 | <1% | 215 | $5K | |
| 99091 | <1% | 460 | $5K | |
| 64494 | <1% | 217 | $5K | |
| 96156 | <1% | 105 | $5K | |
| 95251 | <1% | 228 | $5K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 304 | $4K |
| 90688 | <1% | 244 | $4K | |
| 3074F | <1% | 24,681 | $3K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 108 | $3K |
| 93308 | <1% | 149 | $3K | |
| 3078F | <1% | 20,533 | $3K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 537 | $3K |
| 1160F | <1% | 31,030 | $2K | |
| 82962 | <1% | 1,019 | $2K | |
| 99442 | <1% | 140 | $2K | |
| 94060 | <1% | 77 | $2K | |
| 96127 | <1% | 583 | $2K | |
| 94729 | <1% | 64 | $2K | |
| 93458 | <1% | 13 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 200 | $1K |
| 94727 | <1% | 63 | $1K | |
| 93299 | <1% | 207 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,654 | $1K |
| 11900 | <1% | 127 | $1K | |
| 95249 | <1% | 27 | $1K | |
| 99072 | <1% | 5,903 | $1K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 24 | $1K |
| 2000F | <1% | 22,144 | $1K | |
| 3008F | <1% | 30,233 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,138 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 87 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 524 | $1K |
| 31575 | <1% | 13 | $1K | |
| 90961 | <1% | 14 | $1K | |
| 92550 | <1% | 58 | $1K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 89 | $1K |
| 1036F | <1% | 18,595 | $1K | |
| 93321 | <1% | 134 | $962.85 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $915.61 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 84 | $767.83 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 571 | $671.76 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 502 | $514.52 |
| 99292 | <1% | 12 | $498.83 | |
| 90715 | <1% | 12 | $473.16 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 19 | $466.20 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 38,060 | $410.45 |
| 81025 | <1% | 172 | $399.08 | |
| 3079F | <1% | 9,457 | $367.89 | |
| 92227 | <1% | 47 | $362.66 | |
| 99221 | <1% | 12 | $342.59 | |
| 94760 | <1% | 3,896 | $314.65 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 381 | $308.28 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 111 | $305.61 |
| 1000F | <1% | 4,902 | $271.89 | |
| 93298 | <1% | 12 | $245.93 | |
| G8785 | Blood pressure reading not documented, reason not given | <1% | 1,170 | $244.20 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 531 | $203.95 |
| 83655 | <1% | 1,076 | $151.80 | |
| 93325 | <1% | 123 | $147.57 | |
| 93016 | <1% | 14 | $146.17 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 8,784 | $141.09 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 353 | $140.17 |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | <1% | 13 | $137.63 |
| 97802 | <1% | 13 | $121.40 | |
| 1111F | <1% | 1,471 | $114.36 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 12 | $109.37 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 27 | $108.71 |
| 81002 | <1% | 1,351 | $104.57 | |
| 99173 | <1% | 982 | $71.42 | |
| 99402 | <1% | 219 | $56.93 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 183 | $53.10 |
| 92567 | <1% | 28 | $45.48 | |
| 20550 | <1% | 12 | $45.33 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 435 | $40.00 |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 92 | $25.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 15,649 | $23.48 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 26 | $23.16 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 89 | $22.26 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 14 | $17.56 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $12.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | <1% | 3,891 | $9.51 |
| 99406 | <1% | 61 | $9.50 | |
| 4274F | <1% | 627 | $1.50 | |
| 3037F | <1% | 9,594 | $1.21 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 16,197 | $0.25 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 13,133 | $0.09 |
| G9920 | Screening performed and negative | <1% | 845 | $0.02 |
| 3077F | <1% | 3,042 | $0.01 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 436 | $0.01 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 55 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 248 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 174 | $0.00 |
| 99401 | 0% | 365 | $0.00 | |
| 3051F | 0% | 25 | $0.00 | |
| 99408 | 0% | 40 | $0.00 | |
| 97803 | 0% | 13 | $0.00 | |
| 4040F | 0% | 31 | $0.00 | |
| 3045F | 0% | 12 | $0.00 | |
| 90461 | 0% | 12 | $0.00 | |
| 3075F | 0% | 2,775 | $0.00 | |
| 3080F | 0% | 1,384 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,625 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 104 | $0.00 |
| 3017F | 0% | 37 | $0.00 | |
| 3044F | 0% | 1,042 | $0.00 | |
| 0513F | 0% | 245 | $0.00 | |
| 3510F | 0% | 12 | $0.00 | |
| 1126F | 0% | 55 | $0.00 | |
| 3279F | 0% | 25 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 173 | $0.00 |
| G8542 | Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required | 0% | 171 | $0.00 |
| 1125F | 0% | 12 | $0.00 | |
| 3035F | 0% | 80 | $0.00 | |
| 99441 | 0% | 29 | $0.00 | |
| 86580 | 0% | 44 | $0.00 | |
| G9007 | Coordinated care fee, scheduled team conference | 0% | 17 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJEEREDDI, PRASAD (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Chaparral Medical Group INC. | Bakersfield, CA | $574K |
| Chaparral Medical Group, INC. | Pomona, CA | $208K |
| Chaparral Medical Group, INC. | Rancho Cucamonga, CA | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.